Topics dealing with respiratory diseases and N-Acetylcystein |
| Introduction: |
One of the main applications of N-Acetylcysteine (NAC) is the treatment of some pulmonary diseases (bronchitis). NAC breaks up the mucus and facilitates the expectoration of sputum. NAC has been used since 1960s and has only very small side effects (in some cases it can aggravate asthma).
The literature for the use of NAC in the treatment of respiratory diseases is complex (around 3000-4000 papers) and with little controversy.
Please read the excellent reviews in the literature section of this page.
| Literature: |
N-acetylcysteine, a Review of Efficacy in Pulmonary Disease by Kasra Pournadeali, N.D. LINK
A Cost-Effectiveness Analysis of Oral N-Acetylcysteine as a Preventive Treatment in Chronic Bronchitis
E.M. Grandjean, PH. Berthet, R. Ruffmann and PH. Leuenberger
Pharmacological Research, Vol. 42, No. 1, 2000 Abstract IDEALPlease note the global literature section.
| Information: |
PLEASE send information about new research efforts to nac@acetylcysteine.org .
New topics can be free hosted on this domain or linked to www.acetylcysteine.org .
For discussions please use the Message Board. Thank you!
| Forum: |
On the message board you can discuss this specific topic or can ask other people.
For posting a message please use <Login to post> and hold your E-Mail and PasswordGo to: Message Board NAC and bronchopulmonary diseases
go to: Message Board TOP
A forum for all kind of stuff dealing with
N-Acetylcysteine
Please feel free to contribute in any way.